Követés
Mark Y. Chan
Mark Y. Chan
National University Heart Centre Singapore
E-mail megerősítve itt: nus.edu.sg - Kezdőlap
Cím
Hivatkozott rá
Hivatkozott rá
Év
Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction
MY Chan, JL Sun, LK Newby, LK Shaw, M Lin, ED Peterson, RM Califf, ...
Circulation 119 (24), 3110-3117, 2009
3372009
The global burden of metabolic disease: Data from 2000 to 2019
NWS Chew, CH Ng, DJH Tan, G Kong, C Lin, YH Chin, WH Lim, ...
Cell Metabolism 35 (3), 414-428. e3, 2023
3212023
Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy
PA Gurbel, D Erlinge, EM Ohman, B Neely, M Neely, SG Goodman, ...
Jama 308 (17), 1785-1794, 2012
2722012
Current and novel biomarkers of thrombotic risk in COVID-19: a consensus statement from the international COVID-19 thrombosis biomarkers colloquium
DA Gorog, RF Storey, PA Gurbel, US Tantry, JS Berger, MY Chan, ...
Nature Reviews Cardiology 19 (7), 475-495, 2022
2672022
Obstructive sleep apnea and cardiovascular events after percutaneous coronary intervention
CH Lee, R Sethi, R Li, HH Ho, T Hein, MH Jim, G Loo, CY Koo, XF Gao, ...
Circulation 133 (21), 2008-2017, 2016
2372016
The East Asian paradox: an updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease
HK Kim, US Tantry, SC Smith Jr, MH Jeong, SJ Park, MH Kim, DS Lim, ...
Thrombosis and haemostasis 121 (04), 422-432, 2021
2112021
Coronavirus-induced myocarditis: a meta-summary of cases
JSY Ho, CH Sia, MYY Chan, W Lin, RCC Wong
Heart & Lung 49 (6), 681-685, 2020
1812020
An observational data meta-analysis on the differences in prevalence and risk factors between MAFLD vs NAFLD
GEH Lim, A Tang, CH Ng, YH Chin, WH Lim, DJH Tan, JN Yong, J Xiao, ...
Clinical Gastroenterology and Hepatology 21 (3), 619-629. e7, 2023
1792023
Global prevalence and clinical characteristics of metabolic-associated fatty liver disease: a meta-analysis and systematic review of 10 739 607 individuals
KE Chan, TJL Koh, ASP Tang, J Quek, JN Yong, P Tay, DJH Tan, WH Lim, ...
The Journal of Clinical Endocrinology & Metabolism 107 (9), 2691-2700, 2022
1772022
Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching …
S Brugaletta, T Gori, AF Low, P Tousek, E Pinar, J Gomez-Lara, ...
JACC: Cardiovascular Interventions 8 (1 Part B), 189-197, 2015
1752015
Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease
MY Chan, MG Cohen, CK Dyke, SK Myles, LG Aberle, M Lin, J Walder, ...
Circulation 117 (22), 2865-2874, 2008
1662008
Hypercoagulable states in cardiovascular disease
MY Chan, F Andreotti, RC Becker
Circulation 118 (22), 2286-2297, 2008
1622008
Acute coronary syndrome in the Asia-Pacific region
MY Chan, X Du, D Eccleston, C Ma, PP Mohanan, M Ogita, KG Shyu, ...
international Journal of Cardiology 202, 861-869, 2016
1522016
Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the Global Burden of Disease Study 2019
B Chong, J Jayabaskaran, G Kong, YH Chan, YH Chin, R Goh, S Kannan, ...
EClinicalMedicine 57, 2023
1502023
Severe obstructive sleep apnea and outcomes following myocardial infarction
CH Lee, SM Khoo, MY Chan, HB Wong, AF Low, QH Phua, AM Richards, ...
Journal of Clinical Sleep Medicine 7 (6), 616-621, 2011
1462011
Incidence and predictors of left ventricular thrombus by cardiovascular magnetic resonance in acute ST-segment elevation myocardial infarction treated by primary percutaneous …
H Bulluck, MHH Chan, V Paradies, RL Yellon, HH Ho, MY Chan, ...
Journal of Cardiovascular Magnetic Resonance 20 (1), 72, 2018
1392018
A randomized, repeat‐dose, pharmacodynamic and safety study of an antidote‐controlled factor IXa inhibitor
MY Chan, CP Rusconi, JH Alexander, RM Tonkens, RA Harrington, ...
Journal of Thrombosis and Haemostasis 6 (5), 789-796, 2008
1362008
First clinical application of an actively reversible direct factor IXa inhibitor as an anticoagulation strategy in patients undergoing percutaneous coronary intervention
MG Cohen, DA Purdy, JS Rossi, LR Grinfeld, SK Myles, LH Aberle, ...
Circulation 122 (6), 614-622, 2010
1072010
A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study
X Lu, Z Liu, Q Cui, F Liu, J Li, X Niu, C Shen, D Hu, K Huang, J Chen, ...
European heart journal 43 (18), 1702-1711, 2022
1022022
Obesity in COVID-19: a systematic review and meta-analysis
JSY Ho, DI Fernando, MY Chan, CH Sia
Ann Acad Med Singap 49 (12), 996-1008, 2020
982020
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20